Advertisement
Advertisement
PROK
ProKidney Corp. Class A Ordinary Shares
2.18
USDSponsored
+0.23
+11.79%
Apr 17, 16:00 UTC -4
Closed
After-Market
2.15
-0.04
-1.61%
PROK Earnings Reports
Positive Surprise Ratio
PROK beat 11 of 14 last estimates.
79%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$146.54K
/-$0.14
Implied change from Q4 25 (Revenue/ EPS)
-34.87%
/--
Implied change from Q1 25 (Revenue/ EPS)
-36.29%
/+7.69%
ProKidney Corp. Class A Ordinary Shares earnings per share and revenue
On Mar 18, 2026, PROK reported earnings of -0.14 USD per share (EPS) for Q4 25, missing the estimate of -0.12 USD, resulting in a -12.90% surprise. Revenue reached 225.00 thousand, compared to an expected 153.00 thousand, with a 47.06% difference. The market reacted with a -4.44% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -0.14 USD, with revenue projected to reach 146.54 thousand USD, implying an increase of 0.00% EPS, and decrease of -34.87% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Evotec SE - ADR
Report Date
Apr 08, 2026 For Q4 25
Estimate
$0.31
Actual
$0.08
Surprise
-74.45%
Vivos Therapeutics, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$0.49
Actual
-$0.57
Surprise
-17.65%
Traws Pharma, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.24
Actual
$0.63
Surprise
+150.46%
Cosmos Holdings Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.31
Surprise
-659.80%
BIOMERICA INC
Report Date
Apr 13, 2026 For Q3 26
Estimate
-Actual
-$0.44
Surprise
-
FAQ
What were ProKidney Corp. Class A Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, ProKidney Corp. Class A Ordinary Shares reported EPS of -$0.14, missing estimates by -12.9%, and revenue of $225.00K, 47.06% above expectations.
How did the market react to ProKidney Corp. Class A Ordinary Shares's Q4 2025 earnings?
The stock price moved down -4.44%, changed from $2.25 before the earnings release to $2.15 the day after.
When is ProKidney Corp. Class A Ordinary Shares expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for ProKidney Corp. Class A Ordinary Shares's next earnings report?
Based on --
analysts, ProKidney Corp. Class A Ordinary Shares is expected to report EPS of -$0.14 and revenue of $146.54K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement